Philip A. Philip, MD, PhD
Professor, Department of Oncology
Barbara Ann Karmanos Cancer Institute
Dr. Philip is a professor of oncology and medicine at the Karmanos Cancer Institute and Wayne State University School of Medicine in Detroit, Michigan. He leads the gastrointestinal and neuroendocrine tumors multidisciplinary team and is the vice president of medical affairs at Karmanos. He also chairs the pancreatic cancer subcommittee at the Southwest Oncology Group and is a member of the intergroup’s task force on pancreatic cancer. He also sits on the medical advisory board for the Pancreatic Action network (PanCan) and been very active in advocacy and fundraising for cancer. Dr. Philip practices as medical oncologist specializing in gastrointestinal cancers and neuroendocrine tumors.
Dr. Philip graduated from Medical College at the University of Baghdad in Iraq. He earned a doctorate in clinical pharmacology and pharmacogenetics from the University of London. He completed training in medical oncology in the UK (Oxford) and at the MD Anderson Cancer Center in Houston, Texas. Dr. Philip joined faculty at Wayne State University in 1995. His major research interests are in new drug development with special focus on targeted agents against signaling pathways and has been the principal investigator on many phase I-III clinical trials.
He has published/co-authored over 160 peer reviewed manuscripts in addition to book chapters and invited review articles. He also co-edited a book on pancreatic cancer. Dr. Philip has served as a grant reviewer for the NIH, PanCan, Cancer UK and multiple other agencies. He contributes to the design of clinical trials in GI cancers at the national level. He also serves on the editorial board on several national and international journals.